Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim N01 for Platelet Reconstitution After Allo-HSCT
NCT07829952Phase 2Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Science and Technology
- Start
- Nov 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in Thrombocytopenia, sponsored by First Affiliated Hospital of Henan University of Science and Technology. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07829952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07829952.